Browsing: Pharma

Since discontinuing two branded versions of its asthma inhaler Flovent in early 2024, GSK is…

Germany’s Merck KGaA, which achieved solid sales growth in a difficult 2025, could find itself…

Galderma significantly raised its annual peak sales forecast for Nemulvio (nemolizumab) to more than $4…

Leo Pharma has decided to launch the JAK inhibitor cream Anzupgo. The Danish pharmaceutical company,…

Vanda Pharmaceuticals’ seven-year ambition to expand the label for its sleeping drug Hetrios took an…

With significant manufacturing sites already under lockdown in China, CRDMO BioDuro is on a short…

Nearly four years after the lawsuit was filed, and against a backdrop of significant changes…

Nubeka and Kerendia, the main growth drivers for Bayer’s pharmaceutical division, are performing even better…

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1…

NoA Health has appointed former Novo Nordisk and Pfizer employee Luisa Li as CEO, putting…